Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001193805-26-001408·Climb Bio, Inc.
Schedule 13G ownership disclosure
Climb Bio, Inc.
Common Stock · CUSIP: 28658R106
Event date: 2026-10-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deerfield Mgmt, L.P.
Shares: 3,070,000.00 · Class: 5.25%
- Deerfield Management Company, L.P.
Shares: 3,070,000.00 · Class: 5.25%
- Deerfield Partners, L.P.
Shares: 3,070,000.00 · Class: 5.25%
- James E. Flynn
Shares: 3,070,000.00 · Class: 5.25%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-26-001408
- Form type
- SCHEDULE 13G
- Filer
- Climb Bio, Inc.
- CIK
- CIK 1768446
- Filed
- Oct 28, 2026
- Reporting period
- Oct 27, 2026
- Description
- Schedule 13G beneficial ownership